26 August 2022 (Friday) - NEQAS 2204DM

I had a look at NEQAS 2204DM on 28 July when I was presented with a frankly horrible-looking blood film and the description:

"A 67 year old man attends his family doctor following two weeks of fatigue and new abdominal pain. His total white count is  found to be 81 x10^9 and a film is prepared for your attention - what do you think?" 

Quite frankly I thought "yuk" and were it a genuine case I would be phoning the consultant haematologist thereby passing on the problem to someone who would be better placed to deal with it.
However although it is an honest answer of what I would actually do, that isn't what the nice people at NEQAS want to hear.
 

So...

The obvious problem is the white cells. Far too many of them. there are mature granulocytes present, but also myelocytes, myeloblasts  and ruptured myeloid cells. There were a few basophils too, and that is never a good sign. Smear cells were seen too.

The platelet count was raised with large platelets and clumps present. 

The red cells show anisopoikilocytosis with some spherocytes and some red cell fragments.

Is it an acute leukaemia? I don't think so. For all that there are blast cells, there are more mature cells too. And the platelet count was not reduced. The abdo pain together with the red cell picture makes me consider CML... It was a shame that the software didn't allow me to put my findings in order of priority (like it asked me to)

The results came in today…  

This is a blood film from a patient with chronic myeloid leukaemia (CML). The myeloid expansion in blood with a predominance of relatively normal (although not always completely normal) late myeloid precursors (myelocytes) and neutrophils is typical. Blasts and nucleated red cells are often seen but should be infrequent in typical chronic phase CML. Basophilia in blood is typically present, but the basophils may be degranulated or atypical so it is important to specifically seek them on the blood film.

I got that right…

24 August 2022 (Wednesday) - A Reply

Yesterday I said “I’ve emailed the scheme organise to ask if they have changed their way of working”. I got a reply… 

Hi

Thank you for your email.
Yes, you are correct.  The positive reaction in the manufacturer's internal control well renders the test uninterpretable.
Best wishes,

Senior EQA Scientist and Quality Manager

UK NEQAS BTLP



23 August 2022 (Tuesday) - Failing the BTLP-TACT


 

What with holidays and stuff it is ages since I last did a BTLP-TACT exercise…I was given two patients. 

37097 – A thirty-year-old woman in the maternity department in pre-eclampsia requiring group and save.
She grouped as O Rh(D) Positive with a negative antibody screen

68710 - a twenty-year-old woman in out-patients also requiring group and save. She grouped as O but with an indeterminate Rh(D) type, and with antibody screen positive in cells 1 and 2. I requested antibody profiles.
Both the IAT and enzyme panels were positive in cells 1, 2, 3 and 5 corresponding to anti-D and anti-E (but not ruling out anti-Cw)

I’d be intrigued to know more about this patient’s D-type…

I got the thumbs-down. Apparently the ABO group (in the picture above) was uninterpretable. Does the positive control invalidate everything? In the past I thought it did and got a fail for thinking so
I’ve emailed the scheme organise to ask if they have changed their way of working
...